Previous 10 | Next 10 |
Public health officers have been focused on Covid-19 for the last 18 months and all other public health issues have taken a back seat to Covid-19 response efforts. Opioid overdoses have increased during the pandemic. Zynex has seen rapid growth in revenues and earnings but the sto...
Gainers: ERYTECH Pharma (NASDAQ:ERYP) +64%. Allied Healthcare Products (NASDAQ:AHPI) +49%. iFresh (NASDAQ:IFMK) +35%. Marin Software Incorporated (NASDAQ:MRIN) +29%. Atlassian Corporation (NASDAQ:TEAM) +24%. Xiaobai Maimai (NASDAQ:HX) +18%. First High-School Education (NYSE:FHS) +16%. Bridgel...
Image source: The Motley Fool. Zynex, inc (NASDAQ: ZYXI) Q2 2021 Earnings Call Jul 29, 2021 , 4:15 p.m. ET Operator Continue reading For further details see: Zynex, inc (ZYXI) Q2 2021 Earnings Call Transcript
Zynex, Inc. (ZYXI) Q2 2021 Results Conference Call July 29, 2021 04:15 PM ET Company Participants Thomas Sandgaard - President and Chief Executive Officer Daniel Moorhead - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Yi Chen - HC Wainwright Marc Wie...
Zynex (NASDAQ:ZYXI): Q2 GAAP EPS of $0.08 beats by $0.01. Revenue of $31M (+61.0% Y/Y) misses by $0.26M. Adjusted EBITDA was $4.8 million Shares -1.4%. Press Release For further details see: Zynex EPS beats by $0.01, misses on revenue
Zynex Announces 2021 Second Quarter Earnings PR Newswire ENGLEWOOD, Colo. , July 29, 2021 /PRNewswire/ -- 2021 Second Quarter Revenue increased 61% year over year to $31.0 million Orders increased 247% Net income ...
Zynex Schedules 2021 Second Quarter Earnings Call PR Newswire ENGLEWOOD, Colo., July 21, 2021 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pa...
Zynex Announces 247% Order Growth and Increases Q2 Adjusted EBITDA Estimate PR Newswire ENGLEWOOD, Colo. , July 15, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive me...
Zynex Announces Uplisting to the Nasdaq Global Select Market® PR Newswire ENGLEWOOD, Colo. , July 13, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medi...
Zynex to Present at the Ladenburg Thalmann Virtual Annual Healthcare Conference PR Newswire ENGLEWOOD, Colo. , July 8, 2021 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-i...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Zynex Inc CEO Thomas Sandgaard joined Steve Darling from Proactive to announce the company's financial and operational results for the second quarter ending June 30, 2024, in an interview with Proactive. The company achieved a remarkable 20% year-over-year increase in orde...
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...